title: Is atropine infusion necessary to achieve the target heart rate in heart transplant patients during dobutamine stress echocardiography?
authors.affiliation: Heart Failure and Transplantation Program, Hospital 12 de Octubre, Madrid, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Flox
authors.forename: V
authors.initials: V
authors.lastname: Sánchez
authors.forename: J F
authors.initials: JF
authors.lastname: Delgado
authors.forename: S
authors.initials: S
authors.lastname: Fernández
authors.forename: R
authors.initials: R
authors.lastname: Tello
authors.forename: J
authors.initials: J
authors.lastname: Jiménez
authors.forename: J
authors.initials: J
authors.lastname: García
authors.forename: M A
authors.initials: MA
authors.lastname: Gómez
authors.forename: F
authors.initials: F
authors.lastname: Lombera
authors.forename: C
authors.initials: C
authors.lastname: Sáenz de la Calzada
mesh_terms: D000318:Adrenergic beta-Agonists; D001285:Atropine / Q000008:administration & dosage / Q000494:pharmacology*; D004280:Dobutamine; D004452:Echocardiography / Q000187:drug effects*; D005080:Exercise Test; D006339:Heart Rate / Q000187:drug effects*; D016027:Heart Transplantation / Q000502:physiology*; D006801:Humans; D007262:Infusions, Intravenous; D018727:Muscarinic Antagonists / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D000318:Adrenergic beta-Agonists; D018727:Muscarinic Antagonists; D004280:Dobutamine; D001285:Atropine